Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 468

1.

Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.

Hottes TS, Lester RT, Hoang LM, McKay R, Imperial M, Gilbert M, Patrick D, Wong T, Martin I, Ogilvie G.

Sex Transm Dis. 2013 Jan;40(1):46-51. doi: 10.1097/OLQ.0b013e31827bd64c.

PMID:
23250301
2.

Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.

Kirkcaldy RD, Harvey A, Papp JR, Del Rio C, Soge OO, Holmes KK, Hook EW 3rd, Kubin G, Riedel S, Zenilman J, Pettus K, Sanders T, Sharpe S, Torrone E.

MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.

PMID:
27414503
3.

Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.

Starnino S; GASP-LAC Working Group, Galarza P, Carvallo ME, Benzaken AS, Ballesteros AM, Cruz OM, Hernandez AL, Carbajal JL, Borthagaray G, Payares D, Dillon JA.

Sex Transm Dis. 2012 Oct;39(10):813-21.

PMID:
23001269
5.

Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.

Brunner A, Nemes-Nikodem E, Mihalik N, Marschalko M, Karpati S, Ostorhazi E.

BMC Infect Dis. 2014 Aug 6;14:433. doi: 10.1186/1471-2334-14-433.

6.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.

Dillon JA, Li H, Sealy J, Ruben M, Prabhakar P; Caribbean GASP Network. Gonococcal Antimicrobial Surveillance Program.

Sex Transm Dis. 2001 Sep;28(9):508-14.

PMID:
11518867
7.

Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.

Kovari H, de Melo Oliveira MD, Hauser P, Läuchli S, Meyer J, Weber R, Zbinden R.

BMC Infect Dis. 2013 Dec 26;13:603. doi: 10.1186/1471-2334-13-603.

8.

Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998.

Dillon JA, Rubabaza JP, Benzaken AS, Sardinha JC, Li H, Bandeira MG, dos Santos Fernando Filho E.

Sex Transm Dis. 2001 Sep;28(9):521-6.

PMID:
11518869
9.

High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in Kampala, Uganda (2008-2009).

Vandepitte J, Hughes P, Matovu G, Bukenya J, Grosskurth H, Lewis DA.

Sex Transm Dis. 2014 Apr;41(4):233-7. doi: 10.1097/OLQ.0000000000000099.

PMID:
24622633
10.

Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Jul 8;60(26):873-7.

11.

Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.

Singh AE, Gratrix J, Read R, Lovgren M, Drews SJ, Romanowski B, Sutherland K, Talbot J, Martin I.

Sex Transm Dis. 2013 Sep;40(9):744-50. doi: 10.1097/01.olq.0000431356.80840.d4.

PMID:
23945428
12.

Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.

Mehta SD, Maclean I, Ndinya-Achola JO, Moses S, Martin I, Ronald A, Agunda L, Murugu R, Bailey RC, Melendez J, Zenilman JM.

Antimicrob Agents Chemother. 2011 Aug;55(8):3882-8. doi: 10.1128/AAC.00155-11. Epub 2011 May 23.

13.

Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.

Martin I, Jayaraman G, Wong T, Liu G, Gilmour M; Canadian Public Health Laboratory Network.

Sex Transm Dis. 2011 Oct;38(10):892-8. doi: 10.1097/OLQ.0b013e31822c664f.

PMID:
21934558
14.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.

Jiang FX, Lan Q, Le WJ, Su XH.

BMC Infect Dis. 2017 May 25;17(1):366. doi: 10.1186/s12879-017-2472-z.

15.

Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.

Knapp JS, Wongba C, Limpakarnjanarat K, Young NL, Parekh MC, Neal SW, Buatiang A, Chitwarakorn A, Mastro TD.

Sex Transm Dis. 1997 Mar;24(3):142-8.

PMID:
9132980
16.

Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.

Mlynarczyk-Bonikowska B, Serwin AB, Golparian D, Walter de Walthoffen S, Majewski S, Koper M, Malejczyk M, Domeika M, Unemo M.

BMC Infect Dis. 2014 Feb 6;14:65. doi: 10.1186/1471-2334-14-65.

17.

Correlation between In vitro susceptibility and treatment outcome with azithromycin in gonorrhoea: a prospective study.

Khaki P, Bhalla P, Sharma A, Kumar V.

Indian J Med Microbiol. 2007 Oct;25(4):354-7.

19.

Trends in antimicrobial resistance in Neisseria gonorrhoeae in the USA: the Gonococcal Isolate Surveillance Project (GISP), January 2006-June 2012.

Kirkcaldy RD, Kidd S, Weinstock HS, Papp JR, Bolan GA.

Sex Transm Infect. 2013 Dec;89 Suppl 4:iv5-10. doi: 10.1136/sextrans-2013-051162.

PMID:
24243881
20.

Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.

Cole MJ, Spiteri G, Chisholm SA, Hoffmann S, Ison CA, Unemo M, Van de Laar M.

Euro Surveill. 2014 Nov 13;19(45):20955.

Supplemental Content

Support Center